Loading...
XSTO
OSSD
Market cap45mUSD
Jul 09, Last price  
3.95SEK
1D
-4.59%
1Q
12.86%
IPO
-82.83%
Name

OssDsign AB

Chart & Performance

D1W1MN
XSTO:OSSD chart
P/E
P/S
2.43
EPS
Div Yield, %
Shrs. gr., 5y
34.39%
Rev. gr., 5y
48.59%
Revenues
180m
+34.51%
4,194,9667,682,00013,264,00016,873,00024,872,00031,726,00056,985,000112,157,000133,940,000180,159,000
Net income
-51m
L+2.68%
-28,514,666-63,272,000-56,011,000-84,245,000-84,590,000-93,918,000-99,387,000-130,493,000-49,657,000-50,988,000
CFO
-64m
L+2.65%
-40,613,000-66,052,000-86,593,000-79,098,000-89,784,000-89,229,000-93,909,000-62,379,000-64,034,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

OssDsign AB (publ) specializes in the innovation, manufacturing, and distribution of advanced implant and material technologies crucial for bone regeneration. The company operates across a broad international market, including Sweden, Germany, the United States, the United Kingdom, the wider European region, and other global territories. Its product line features OSSDSIGN cranial, a comprehensive implant and accessory system engineered for the reconstruction of skull defects in cranioplasty procedures. Another key offering, OSSDSIGN facial, is designed to correct skeletal deformities, whether they arise from trauma or are congenital. Additionally, OssDsign provides the OSSDSIGN Cranioplug, which serves to secure bone flaps and cover burr holes, and OssDsign Catalyst, a cutting-edge nanosynthetic bone graft substitute specifically formulated to stimulate healthy bone tissue formation. Established in 2011, the company maintains its primary operational base in Uppsala, Sweden.
IPO date
May 24, 2019
Employees
50
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT